Potential Feasibility of Atezolizumab-Bevacizumab Therapy in Patients with Hepatocellular Carcinoma Treated with Tyrosine-Kinase Inhibitors
Benedetta Stefanini,Laura Bucci,Valentina Santi,Nicola Reggidori,Davide Rampoldi,Lorenzo Lani,Alessandro Granito,Angelo Sangiovanni, Giuseppe Cabibbo, Fabio Farinati,Claudia Campani, Francesco Giuseppe Foschi, Gianluca Svegliati-Baroni,Giovanni Raimondo,Antonio Gasbarrini,Andrea Mega,Elisabetta Biasini, Rodolfo Sacco,Filomena Morisco, Eugenio Caturelli,Gianpaolo Vidili, Francesco Azzaroli, Edoardo G. Giannini,Gian Ludovico Rapaccini, Maurizia Rossana Brunetto,Alberto Masotto,Gerardo Nardone,Mariella Di Marco,Donatella Magalotti,Franco Trevisani, Italian Liver Canc ITALICA Grp Digestive and Liver Disease（2022）
关键词
Hepatocellular carcinoma,Systemic therapy,Atezolizumab-bevacizumab,Tirosin-kinase inhibitor
AI 理解论文
溯源树
样例
